Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.
Press releases published on August 25, 2025
Fiverr to Present at Upcoming Conference
GlobeNewswire
·
August 25, 2025
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Fiverr International Ltd. (NYSE: FVRR), the company that is transforming the way the world creates and works together, today announced that Micha Kaufman, Founder and Chief Executive Officer, will present at the …
SCYNEXIS to Participate in the H.C. Wainwright 27th Annual Global Conference September 8 – 10, 2025
GlobeNewswire
·
August 25, 2025
JERSEY CITY, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that the Scynexis senior …
Avalyn to Participate in Multiple Upcoming Investor Conferences in September
GlobeNewswire
·
August 25, 2025
CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management …
Ardelyx to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 25, 2025
WALTHAM, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Fate Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 25, 2025
SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular …
ORYZON Receives European Medicines Agency Approval to Initiate a Phase Ib Study of Iadademstat in Sickle Cell Disease
GlobeNewswire
·
August 25, 2025
First iadademstat clinical trial in non-malignant hematological indications MADRID and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a …
BridgeBio to Present Additional Open-label Extension Data from ATTRibute-CM at ESC Congress 2025
GlobeNewswire
·
August 25, 2025
PALO ALTO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that one rapid-fire oral presentation on …
Spectral Medical Receives US$3 Million From Vantive
GlobeNewswire
·
August 25, 2025
TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that it has received the US$3 million …
Incyclix Bio Secures $11.25 Million Series B Extension to Advance the Phase 1/2 Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors
GlobeNewswire
·
August 25, 2025
RESEARCH TRIANGLE PARK, N.C., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, a next-generation cell cycle control company developing INX-315, a novel, potent and selective CDK2 inhibitor for the treatment of advanced and resistant cancer, today …
Major Drilling to Release Results for its First Quarter on September 8, 2025
GlobeNewswire
·
August 25, 2025
MONCTON, New Brunswick, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Major Drilling Group International Inc. (TSX: MDI) (the “Company”) will release its first quarter results, ended July 31, 2025, on Monday, September 8, 2025 after the markets have closed. Webcast/ …
Apollo Expands Project Team; Receives Drill Permit for Calico Silver Project
GlobeNewswire
·
August 25, 2025
VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Apollo Silver Corp. (“Apollo” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to announce a number of positive developments at its Calico Silver Project (“Calico” or the …
Erdene Provides Update on Share Consolidation
GlobeNewswire
·
August 25, 2025
HALIFAX, Nova Scotia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Erdene Resource Development Corp. (TSX: ERD; MSE: ERDN; OTCQB: ERDCF) ("Erdene" or the "Company") is pleased to provide an update on the proposed consolidation (the "Consolidation") of Company's …
Babak Baru Kehidupan Pasien: KFSHRC Mengobati Penyakit Langka Setelah Pengobatan Khusus 22 Tahun
GlobeNewswire
·
August 25, 2025
RIYADH, Arab Saudi, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Dalam sebuah kisah langka tentang ikatan seumur hidup antara seorang pasien dan suatu lembaga kesehatan, King Faisal Specialist Hospital …
KFSHRC, 22년간 이어진 전문 진료로 희귀병 환자 치료 성공
GlobeNewswire
·
August 25, 2025
사우디아라비아 리야드, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 리야드에 위치한 킹 파이살 전문병원 겸 연구센터 (KFSHRC)는 환자와 의료 기관 사이에 평생에 걸친 유대라는 드문 사례를 보여주듯, 한 환자를 영아기부터 지원해 왔으며, 희귀 유전성 혈액 응고 장애에 대해 22년간 지속적인 치료를 제공한 끝에 세계 최초로 이 질환 환자에게 간 이식을 성공적으로 시행하는데 마침내 성공했다. 환자의 생후 몇 개월 무렵 첫 번째 질환 징후가 …
新たに生まれ変わる人生： キング・ファイサル・スペシャリスト病院・研究センター (King Faisal Specialist Hospital & Research Centre、KFSHRC)、22年にわたる専門治療の末に希少疾患を治療
GlobeNewswire
·
August 25, 2025
サウジアラビア、リヤド発, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 患者と医療機関の生涯にわたる絆を示す珍しい例として、リヤドのキング・ファイサル・スペシャリスト病院・研究センター (KFSHRC) は、希少な遺伝性血液凝固障害の患者を乳幼児期から支え続け、22年間にわたり継続的に治療を提供し、最終的にこの特殊な疾患では世界初となる肝臓移植を実現した。 生後数カ月で病気の初期症状が現れたとき、KFSHRCは、患者の病状を安定させるため、奔走した。 …
Transformasi Hidup: KFSHRC Berjaya Rawat Penyakit Jarang Selepas 22 Tahun Penjagaan Rapi
GlobeNewswire
·
August 25, 2025
RIYADH, Arab Saudi, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Dalam satu kisah luar biasa mengenai ikatan seumur hidup antara pesakit dan institusi penjagaan kesihatan, King Faisal Specialist Hospital …
พลิกชีวิตใหม่: KFSHRC รักษาโรคหายากสำเร็จหลังดูแลผู้ป่วยเฉพาะทางมานาน 22 ปี
GlobeNewswire
·
August 25, 2025
กรุงริยาด, ซาอุดีอาระเบีย, Aug. 25, 2025 (GLOBE NEWSWIRE) -- ในตัวอย่างความผูกพันตลอดชีวิตระหว่างผู้ป่วยและสถาบันดูแลสุขภาพที่หาได้ยาก King Faisal Specialist Hospital …
改写人生：22 年专业照护，KFSHRC 治愈罕见病
GlobeNewswire
·
August 25, 2025
利雅得，沙特阿拉伯, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 在医患终生相伴的罕见案例中，利雅得 King Faisal Specialist Hospital …
重獲新生：經歷 22 年專科護理後，KFSHRC 成功治癒罕見疾病
GlobeNewswire
·
August 25, 2025
利雅德，沙地阿拉伯, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 自嬰幼時期開始，利雅德的 King Faisal Specialist Hospital …
NorthWest Upsizes Flow Through Financing to $4.1 Million and Closes Final Tranche
GlobeNewswire
·
August 25, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- NorthWest Copper Corp. (“NorthWest” or “the Company”) (TSX-V: NWST) is pleased to announce it has upsized a second …